-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
September 13, 2011 - Usually, treatment adherence includes medication adherence and regimen adherence. … timing of the prescribed medication. … In our study, we will consider both medication adherence and regimen
adherence. … Interventions for enhancing medication adherence. … Medication compliance and persistence: terminology and
definitions.
-
effectivehealthcare.ahrq.gov/products/depression-care-distributed-networks/abstract
May 08, 2009 - how clinical data from an electronic health record (EHR) can be complemented by other data including medication … Access additional data including medication fulfillment data, diagnostic data, claims and point-of-care
-
effectivehealthcare.ahrq.gov/products/allergy-seasonal/research
July 16, 2013 - Structured Abstract
Objectives
This review compared the effectiveness and common adverse events of medication … SAR and asthma, montelukast was superior to oral selective antihistamine for reduced asthma rescue medication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0623-140828.pdf
April 25, 2014 - Staff-Generated PICO
Population(s): Adult women
Intervention(s): Treatments for infertility: 1) medication … intrauterine insemination, in vitro fertilization
[IVF])
Comparator(s): Within category comparisons (i.e., medication … vs. medication, surgery
vs. surgery, and ART vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1312.pdf
December 01, 2013 - When the patient ingests the medication with embedded sensor,
digestive fluids activate the sensor … Lack of patient adherence to
the medication regimens being tested in clinical trials was cited in a … But some
experts were skeptical about this technology’s potential to improve medication adherence … When the patient
swallows the sensor-embedded pill, the medication releases the chip, which is then … Medication adherence was >85%.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
February 01, 2012 - In general, the choice of medication in children and
adolescents is often driven by side-effect profiles … Do FGAs and SGAs differ in medication-associated
adverse events when used in children, youth, and young … • Medication adherence and persistence.
• School performance and attendance. … Schizophrenia
Medication adherence FGA vs. SGA (2 RCT, 1 PCS) Low No significant difference. … A three-country comparison of psychotropic medication
prevalence in youth.
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
June 01, 2014 - The patient ingests the medication along with the sensor, and digestive fluids activate the
sensor … Lack of patient adherence to the medication regimens tested in clinical trials has been
implicated … Thus, whether this would add to
overall costs or offset costs of nonadherence to medication regimens … among experts about this
technology’s potential to improve medication adherence and health outcomes … Medication adherence was
>85%.
-
effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_june_2012.pdf
January 01, 2012 - Overall High Impact Potential: Intelligent pills to monitor patient medication use .............. 6 … *Intelligent pills (Raisin System ) to monitor patient medication adherence Moderately high
4. … Potential for High Impact: High
Intelligent Pills to Monitor Patient Medication Adherence … Medication adherence was
>85%. … on the way the
medication is prescribed, not necessarily on the way it is actually taken.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - These
studies compared the use of long tolerated
innovator antiepileptic medication with short-term … As such, the switchback from a generic to an
innovator antiepileptic medication may or may not
be due … New Evidence:
Switching from an innovator to a generic antiepileptic
medication … These studies compared the use of long tolerated
innovator antiepileptic medication with short-term … New Evidence:
While data on BCS class for the innovator versus generic
antiepileptic medication
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - These
studies compared the use of long tolerated
innovator antiepileptic medication with short-term … As such, the switchback from a generic to an
innovator antiepileptic medication may or may not
be due … New Evidence:
Switching from an innovator to a generic antiepileptic
medication … These studies compared the use of long tolerated
innovator antiepileptic medication with short-term … New Evidence:
While data on BCS class for the innovator versus generic
antiepileptic medication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-key-question_0.pdf
January 01, 2019 - ages 10-
24y with
suicidal
thoughts
or
behaviors
Intermediate/process outcomes
• Adherence to medication … • Participation in treatment
Harms: medication side
effects, stigma
Interventions (e.g. … Any harms: medication side effects, stigma
Timing All/any (short term, long term)
Figure 1.
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting_hi_impact.pdf
January 01, 2012 - Overall High Impact Potential: Intelligent pills to monitor patient medication use .............. 3 … *Intelligent pills to monitor patient medication use
3. … Medication adherence was >85%. … As one commentator who is a pharmacist stated, “Clinicians might alter or change a
medication based … on the way the medication is prescribed, not necessarily on the way it is actually
taken.
-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - In this situation, the new episode of use
started on the date the new medication was filled. … MPR indicates medication possession ratio. … Adherence to medication. N Engl J Med.
2005;353:487–497.
19. … The language of medication-taking. Ann Intern
Med. 2000;132:926–930.
21. … Evaluating medication effects outside of clinical trials: new-
user designs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
February 01, 2016 - Head-to-head trials have not consistently established
the superiority of one medication over another … Factors that may guide medication choices include frequency of
administration, dosing schedule or other … Medication Outcome
N
Studiesa
N
Subjects Finding Effect Size (95% CI) NNTb SOE
Acamprosate
vs. placebo … b This medication has not been approved by the FDA for the treatment
of alcohol dependence, alcohol … In most studies,
patients abstained for at least 3 days before starting medication.
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
December 01, 2015 - The patient ingests the medication along with the sensor, and
digestive fluids activate the sensor … Lack of patient adherence to medication regimens tested in clinical
trials has been implicated as a … Whether this
will add to overall costs or offset costs of nonadherence to medication regimens is not … or into the active medication itself.2,4,5 The technology’s
manufacturer states that the sensor is … Medication adherence was >85%.
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
June 01, 2015 - The patient ingests the medication
along with the sensor, and digestive fluids activate the sensor … Lack of patient adherence to medication regimens tested in clinical
trials has been implicated as a … Thus,
whether this will add to overall costs or offset costs of nonadherence to medication regimens … Medication adherence was >85%. … Proteus promotes medication adherence
using ingestible sensors. Gray Sheet. 2012 Aug 6.
20.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - ; (4) dose of medication; (5) duration of treatment? … ; (4) dose of medication; (5) the duration of therapy? … *" or "neuromuscular drug*" or "neuromuscular
medication*" or "neuromuscular nondepolarizing agent*" … *" or "neuromuscular
drug*" or "neuromuscular medication*" or "neuromuscular nondepolarizing agent*" … Acute migraine medication and medication
overuse headache: a systematic literature
review.
-
effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
December 26, 2012 - Decisions:
• BCS vs. mastectomy for average risk patients with early stage breast cancer
• Diabetes medication … • Stochastic Uncertainty
• Frequencies (or percentages) Pictographs
Example: MD discussing BP
medication … About 2 out of 100 patients who take this medication will develop low blood pressure. … What not to do:
2 out of 10 patients who
take this medication
could
develop low blood
pressure
-
effectivehealthcare.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_2012-12-11.pdf
January 01, 2012 - Overall high-impact potential: intelligent pills (The Raisin System) to monitor
patient medication … (wound care, medication reconciliation), prevention (immunizations, fall
assessment), and referral … Medication adherence was >85%. … HS262 - Intelligent pills (Raisin System) to
monitor patient medication use in chronic diseases. … HS262 - Intelligent pills (Raisin System) to
monitor patient medication use in chronic diseases.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - ; (4) dose of medication; (5) duration of treatment? … ; (4) dose of medication; (5) the duration of therapy? … *" or "neuromuscular drug*" or "neuromuscular
medication*" or "neuromuscular nondepolarizing agent*" … *" or "neuromuscular
drug*" or "neuromuscular medication*" or "neuromuscular nondepolarizing agent*" … Acute migraine medication and medication
overuse headache: a systematic literature
review.